» Articles » PMID: 24187561

Familial Aggregation of High Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus

Overview
Date 2013 Nov 5
PMID 24187561
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) patients frequently have high circulating tumor necrosis factor alpha (TNF-α) levels. We explored circulating TNF-α levels in SLE families to determine whether high levels of TNF-α were clustered in a heritable pattern. We measured TNF-α in 242 SLE patients, 361 unaffected family members, 23 unaffected spouses of SLE patients, and 62 unrelated healthy controls. Familial correlations and relative recurrence risk rates for the high TNF-α trait were assessed. SLE-affected individuals had the highest TNF-α levels, and TNF-α was significantly higher in unaffected first degree relatives than healthy unrelated subjects (P = 0.0025). No Mendelian patterns were observed, but 28.4% of unaffected first degree relatives of SLE patients had high TNF-α levels, resulting in a first degree relative recurrence risk of 4.48 (P = 2.9 × 10⁻⁵). Interestingly, the median TNF-α value in spouses was similar to that of the first degree relatives. Concordance of the TNF-α trait (high versus low) in SLE patients and their spouses was strikingly high at 78.2%. These data support a role for TNF-α in SLE pathogenesis, and TNF-α levels may relate with heritable factors. The high degree of concordance in SLE patients and their spouses suggests that environmental factors may also play a role in the observed familial aggregation.

Citing Articles

Th1-related transcription factors and cytokines in systemic lupus erythematosus.

Tang Y, Wang D, Chen Y, Xu W, Huang A Front Immunol. 2024; 14:1305590.

PMID: 38164134 PMC: 10757975. DOI: 10.3389/fimmu.2023.1305590.


Systemic lupus erythematosus as a genetic disease.

Harley I, Sawalha A Clin Immunol. 2022; 236:108953.

PMID: 35149194 PMC: 9167620. DOI: 10.1016/j.clim.2022.108953.


Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.

Sinicato N, Postal M, Appenzeller S, Niewold T Pharmaceut Med. 2017; 31(2):81-88.

PMID: 28827978 PMC: 5562038. DOI: 10.1007/s40290-017-0178-6.


Advances in lupus genetics.

Niewold T Curr Opin Rheumatol. 2015; 27(5):440-7.

PMID: 26218512 PMC: 4540605. DOI: 10.1097/BOR.0000000000000205.


Influenza A (H1N1) virus infection triggers severe pulmonary inflammation in lupus-prone mice following viral clearance.

Slight-Webb S, Bagavant H, Crowe S, James J J Autoimmun. 2015; 57:66-76.

PMID: 25563403 PMC: 4324011. DOI: 10.1016/j.jaut.2014.12.003.


References
1.
Niewold T, Kariuki S, Morgan G, Shrestha S, Pachman L . Gene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositis. J Pediatr. 2010; 157(4):653-7. PMC: 2936662. DOI: 10.1016/j.jpeds.2010.04.034. View

2.
Weckerle C, Franek B, Kelly J, Kumabe M, Mikolaitis R, Green S . Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2010; 63(4):1044-53. PMC: 3068224. DOI: 10.1002/art.30187. View

3.
Salloum R, Franek B, Kariuki S, Rhee L, Mikolaitis R, Jolly M . Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 2010; 62(2):553-61. PMC: 2832192. DOI: 10.1002/art.27182. View

4.
Studnicka-Benke A, Steiner G, Petera P, Smolen J . Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol. 1996; 35(11):1067-74. DOI: 10.1093/rheumatology/35.11.1067. View

5.
Kariuki S, Crow M, Niewold T . The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus. Arthritis Rheum. 2008; 58(9):2818-23. PMC: 2621106. DOI: 10.1002/art.23728. View